HIV/AIDS CME

With eight categories of HIV meds now available, healthcare professionals need to be up to date about these therapies. Whether using regimens from 20 years ago, or the newest drugs healthcare professionals need to be monitoring adherence to those regimens. By providing data from the San Francisco Study to show the needs for 95% adherence. This Florida-approved course will also describe the advantages and disadvantages of each category of drugs, as well as those individual drugs.

In this online, self-learning activity:

Human immunodeficiency virus (HIV) is a retrovirus that preferentially targets CD4+ T lymphocytes, driving chronic immune activation, CD4+ depletion, and heightened vulnerability of people living with it (PLWH) to opportunistic infections and certain malignancies. Early, guideline-concordant primary care engagement is essential to mitigate these risks and optimize long-term outcomes. Contemporary antiretroviral therapy (ART) recommendations from major panels provide multiple highly effective, well-tolerated options that enable durable viral suppression when initiated promptly and supported over time.